Low IL-10/TNFα Ratio in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction with a Poor Prognosis After 10 Years

Inflammation

Volumn 38, Issue 2, 2015, Pages 911-922

  Dopheide, Jörn F ^a   Knopf, Pascal ^a   Zeller, Geraldine C ^a   Vosseler, Markus ^a   Abegunewardene, Nico ^a   Münzel, Thomas ^a   Espinola Klein, Christine ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

coronary artery disease; dendritic cells; IL 10 TNF ratio; inflammation; monocytes

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CELL COUNT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; HYPERTENSION; IN VITRO STUDY; MALE; MIDDLE AGED; MONOCYTE; MONOCYTOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING; STABLE ANGINA PECTORIS; BLOOD; HEART STROKE VOLUME; MORTALITY; PHYSIOLOGY; SURVIVAL RATE; TIME; TRENDS;

AGED; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84925520061     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0053-5     Document Type: Article

References (45)

1. Ross, R. 1999. Atherosclerosis: an inflammatory disease. The New England Journal of Medicine 340: 115–126.
2. Hansson, G.K. 2001. Regulation of immune mechanisms in atherosclerosis. The Annals of the New York Academy of Sciences 947: 157–165.
3. Hansson, G.K., P. Libby, U. Schonbeck, and Z.Q. Yan. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circulation Research 91(4): 281–291.
4. Lotze, M.T., and A.W. Thomson. 2001. Dendritic cells: biology and clinical applications, 2nd ed. San Diego: Academic.
5. Galkina, E., and K. Ley. 2009. Immune and inflammatory mechanisms of atherosclerosis (*). Annual Review of Immunology 27: 165–197.
6. Jovinge, S., M.P.S. Ares, B. Kallin, and J. Nilsson. 1996. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arteriosclerosis, Thrombosis, and Vascular Biology 16(12): 1573–1579.
7. Nouri-Shirazi, M., and E. Guinet. 2003. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 109(3): 365–373.
8. Guinet, E., K. Yoshida, and M. Nouri-Shirazi. 2004. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunology Letters 95(1): 45–55.
9. Alderman, C.J.J., R. Bunyarad, B.M. Chain, J.C. Foreman, D.S. Leake, and D.R. Katz. 2002. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment. Cardiovascular Research 55: 806–819.
10. Perrin-Cocon, L., F. Coutant, S. Agaugue, S. Deforges, P. Andre, and V. Lotteau. 2001. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. Journal of Immunology 167(7): 3785–3791.
11. Aicher, A., C. Heeschen, M. Mohaupt, J.P. Cooke, A. Zeiher, and S. Dimmeler. 2003. Nicotine strongly activates dendritic cell-mediated adaptive immunity. Potential role for progression of atherosclerotic lesions. Circulation 107: 604–611.
12. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of levels of IL-12 and enhances T-cell stimulatory capacity: T-T help via APC activation. The Journal of Experimental Medicine 184: 747–752.
13. Woollard, K.J., and F. Geissmann. 2010. Monocytes in atherosclerosis: subsets and functions. Nature Reviews Cardiology 7(2): 77–86.
14. Niessner, A., and C.M. Weyand. 2010. Dendritic cells in atherosclerotic disease. Clinical Immunology 134(1): 25–32.
15. Cesari, M., B.W.J.H. Penninx, A.B. Newman, S.B. Kritchevsky, B.J. Nicklas, K. Sutton-Tyrrell, S.M. Rubin, J. Ding, E.M. Simonsick, T.B. Harris, and M. Pahor. 2003. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108(19): 2317–2322.
16. Heeschen, C., S. Dimmeler, C.W. Hamm, S. Fichtlscherer, E. Boersma, M.L. Simoons, A.M. Zeiher, and Investigators ftCS. 2003. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107(16): 2109–2114.
17. Blankenberg, S., L. Tiret, C. Bickel, D. Peetz, F. Cambien, J. Meyer, H.J. Rupprecht, and for the AtheroGene investigators. 2002. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106(1): 24–30.
18. Pickl, W., O. Majdic, P. Kohl, J. Stockl, E. Riedl, C. Scheinecker, C. Bello-Fernandez, and W. Knapp. 1996. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. Journal of Immunology 157(9): 3850–3859.
19. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical application. Journal of Immunological Methods 196: 137–151.
20. Sester, M., U. Sester, B. Gartner, G. Heine, M. Girndt, N. Mueller-Lantzsch, A. Meyerhans, and H. Kohler. 2001. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation1. Transplantation 71(9): 1287–1294.
21. De Backer, J., R. Mark, D. De Bacquer, L. Van Renterghem, E. Verbraekel, M. Kornitzer, and G. De Backer. 2002. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 160: 457–463.
22. Fernandes, J.L., R.L. Mamoni, J.L. Orford, C. Garcia, A.P. Selwyn, O.R. Coelho, and M.H. Blotta. 2004. Increased Th1 activity in patients with coronary artery disease. Cytokine 26(3): 131–137.
23. Mizia-Stec, K., T. Mandecki, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, and L. Szymanski. 2002. Is there a relationship between left ventricular systolic function and serum cytokines level in patients with coronary artery disease? Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 8(2): CR87–92.
24. Mizia-Stec, K., Z. Gasior, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, and I. Kobielusz-Gembala. 2003. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coronary Artery Disease 14(6): 431–438.
25. Schlitt, A., G.H. Heine, S. Blankenberg, C. Espinola-Klein, J.F. Dopheide, C. Bickel, K.J. Lackner, M. Iz, J. Meyer, H. Darius, and H.J. Rupprecht. 2004. CD14+ CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thrombosis and Haemostasis 92(2): 419–424.
26. Dopheide, J.F., U. Sester, A. Schlitt, G. Horstick, H.J. Rupprecht, T. Munzel, and S. Blankenberg. 2007. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coronary Artery Disease 18(7): 523–531.
27. Delirezh, N., and E. Shojaeefar. 2012. Phenotypic and functional comparison between flask adherent and magnetic activated cell sorted monocytes derived dendritic cells. Iranian Journal of Immunology: IJI 9(2): 98–108.
28. Delirezh, N., E. Shojaeefar, P. Parvin, and B. Asadi. 2013. Comparison the effects of two monocyte isolation methods, plastic adherence and magnetic activated cell sorting methods, on phagocytic activity of generated dendritic cells. Cell Journal 15(3): 218–223.
29. Lim WH, Kireta S, Leedham E, Russ GR, Coates PT. 2007. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients.
30. Lim, W.H., S. Kireta, A.W. Thomson, G.R. Russ, and P.T. Coates. 2006. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation 81(2): 160–168.
31. Devereux, R.B., M.J. Roman, V. Palmieri, J.E. Liu, E.T. Lee, L.G. Best, R.R. Fabsitz, R.J. Rodeheffer, and B.V. Howard. 2003. Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. American Heart Journal 146(3): 527–534.
32. Niethammer, M., M. Sieber, S. von Haehling, S.D. Anker, T. Munzel, G. Horstick, and S. Genth-Zotz. 2008. Inflammatory pathways in patients with heart failure and preserved ejection fraction. International Journal of Cardiology 129(1): 111–117.
33. Gullestad, L., T. Ueland, J.G. Fjeld, E. Holt, T. Gundersen, K. Breivik, M. Folling, A. Hodt, R. Skardal, J. Kjekshus, A. Andreassen, E. Kjekshus, R. Wergeland, A. Yndestad, S.S. Froland, A.G. Semb, and P. Aukrust. 2005. Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study. Circulation 112(22): 3408–3414.
34. Sliwa, K., O. Forster, E. Libhaber, J.D. Fett, J.B. Sundstrom, D. Hilfiker-Kleiner, and A.A. Ansari. 2006. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. European Heart Journal 27(4): 441–446.
35. Dhingra S, Sharma AK, Singla DK, Singal PK. 2007. p38 and ERK1/2 MAPKs mediate the interplay of TNF-α and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Vol 293;.
36. Kaur, K., A.K. Sharma, S. Dhingra, and P.K. Singal. 2006. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. Journal of Molecular and Cellular Cardiology 41(6): 1023–1030.
37. Stumpf, C., C. Lehner, A. Yilmaz, W.G. Daniel, and C.D. Garlichs. 2003. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clinical Science 105(1): 45–50.
38. Waehre, T., B. Halvorsen, J.K. Damas, A. Yndestad, F. Brosstad, L. Gullestad, J. Kjekshus, S.S. Froland, and P. Aukrust. 2002. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. European Journal of Clinical Investigation 32(11): 803–810.
39. Kelly, Á., A. Lynch, E. Vereker, Y. Nolan, P. Queenan, E. Whittaker, L.A.J. O’Neill, and M.A. Lynch. 2001. The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1β on long term potentiation. A role for JNK. Journal of Biological Chemistry 276(49): 45564–45572.
40. Mann, D.L. 1996. The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. Journal of Cardiac Failure 2(4 Suppl): S165–172.
41. Della Bella, S., S. Giannelli, A. Taddeo, P. Presicce, and M.L. Villa. 2008. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. Journal of Immunological Methods 339(2): 153–164.
42. Giannelli, S., A. Taddeo, P. Presicce, M.L. Villa, and S.D. Bella. 2008. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry. Part B, Clinical Cytometry 74B(6): 349–355.
43. Dopheide, J.F., V. Obst, C. Doppler, M.C. Radmacher, M. Scheer, M.P. Radsak, T. Gori, A. Warnholtz, C. Fottner, A. Daiber, T. Munzel, and C. Espinola-Klein. 2012. Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease. Thrombosis and Haemostasis 108(6): 1198–1207.
44. + monocytes as a third monocyte subset. Blood 118(12): e50–61.
45. Heimbeck, I., T.P. Hofer, C. Eder, A.K. Wright, M. Frankenberger, A. Marei, G. Boghdadi, J. Scherberich, and L. Ziegler-Heitbrock. 2010. Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry. Part A 77(9): 823–830.